NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | -9.0% | 1,614 | 0.0% | 0.00% | – |
| Q2 2023 | $78 | -12.4% | 1,614 | 0.0% | 0.00% | – |
| Q1 2023 | $89 | +30.9% | 1,614 | -4.9% | 0.00% | – |
| Q4 2022 | $68 | -99.9% | 1,698 | -36.9% | 0.00% | – |
| Q3 2022 | $117,000 | +24.5% | 2,693 | +0.1% | 0.00% | – |
| Q2 2022 | $94,000 | +28.8% | 2,691 | +48.4% | 0.00% | – |
| Q1 2022 | $73,000 | -43.4% | 1,813 | +30.4% | 0.00% | – |
| Q4 2021 | $129,000 | +38.7% | 1,390 | +66.3% | 0.00% | – |
| Q3 2021 | $93,000 | -89.1% | 836 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $851,000 | -70.6% | 7,508 | -73.7% | 0.00% | -75.0% |
| Q1 2021 | $2,899,000 | -20.0% | 28,557 | -21.6% | 0.00% | -20.0% |
| Q4 2020 | $3,624,000 | +3318.9% | 36,421 | +1602.7% | 0.01% | – |
| Q2 2020 | $106,000 | +41.3% | 2,139 | -4.6% | 0.00% | – |
| Q4 2019 | $75,000 | +341.2% | 2,242 | +314.4% | 0.00% | – |
| Q3 2019 | $17,000 | -99.0% | 541 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $1,637,000 | – | 150,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |